Cargando…
Whole lesion quantitative CT evaluation of renal cell carcinoma: differentiation of clear cell from papillary renal cell carcinoma
PURPOSE: Clear cell renal cell carcinoma (ccRCC) is the most common subtype of renal cell cancer (RCC), followed by papillary RCC (pRCC). It is important to distinguish these two subtypes because of prognostic differences and possible changes in management, especially in cases undergoing active surv...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4325006/ https://www.ncbi.nlm.nih.gov/pubmed/25694862 http://dx.doi.org/10.1186/s40064-015-0823-z |
_version_ | 1782356770306392064 |
---|---|
author | Chen, Frank Huhdanpaa, Hannu Desai, Bhushan Hwang, Darryl Cen, Steven Sherrod, Andy Bernhard, Jean-Christophe Desai, Mihir Gill, Inderbir Duddalwar, Vinay |
author_facet | Chen, Frank Huhdanpaa, Hannu Desai, Bhushan Hwang, Darryl Cen, Steven Sherrod, Andy Bernhard, Jean-Christophe Desai, Mihir Gill, Inderbir Duddalwar, Vinay |
author_sort | Chen, Frank |
collection | PubMed |
description | PURPOSE: Clear cell renal cell carcinoma (ccRCC) is the most common subtype of renal cell cancer (RCC), followed by papillary RCC (pRCC). It is important to distinguish these two subtypes because of prognostic differences and possible changes in management, especially in cases undergoing active surveillance. The purpose of our study is to evaluate the use of voxel-based whole-lesion (WL) enhancement parameters on contrast enhanced computed tomography (CECT) to distinguish ccRCC from pRCC. MATERIALS AND METHODS: In this institutional review board-approved study, we retrospectively queried the surgical database for post nephrectomy patients who had pathology proven ccRCC or pRCC and who had preoperative multiphase CECT of the abdomen between June 2009 and June 2011. A total of 61 patients (46 with ccRCC and 15 with pRCC) who underwent robotic assisted partial nephrectomy for clinically localized disease were included in the study. Multiphase CT acquisitions were transferred to a dedicated three-dimensional workstation, and WL regions of interest were manually segmented. Voxel-based contrast enhancement values were collected from the lesion segmentation and displayed as a histogram. Mean and median enhancement and histogram distribution parameters skewness, kurtosis, standard deviation, and interquartile range were calculated for each lesion. Comparison between ccRCC and pRCC was made using each imaging parameter. For mean and median enhancement, which had a normal distribution, independent t-test was used. For histogram distribution parameters, which were not normally distributed, Wilcoxon rank sum test was used. RESULTS: ccRCC had significantly higher mean and median whole WL enhancement (p < 0.01) compared to pRCC on arterial, nephrographic, and excretory phases. ccRCC had significantly higher interquartile range and standard deviation (p < 0.01) and significantly lower skewness (p < 0.01) compared to pRCC on arterial and nephrographic phases. ccRCC had significantly lower kurtosis compared to pRCC on only the arterial phase. CONCLUSION: Our study suggests that voxel-based WL enhancement parameters can be used as a quantitative tool to differentiate ccRCC from pRCC. Differentiating between the two main types of RCC would provide the patient and the treating physicians more information to formulate the initial approach to managing the patient’s renal cancer. |
format | Online Article Text |
id | pubmed-4325006 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-43250062015-02-18 Whole lesion quantitative CT evaluation of renal cell carcinoma: differentiation of clear cell from papillary renal cell carcinoma Chen, Frank Huhdanpaa, Hannu Desai, Bhushan Hwang, Darryl Cen, Steven Sherrod, Andy Bernhard, Jean-Christophe Desai, Mihir Gill, Inderbir Duddalwar, Vinay Springerplus Research PURPOSE: Clear cell renal cell carcinoma (ccRCC) is the most common subtype of renal cell cancer (RCC), followed by papillary RCC (pRCC). It is important to distinguish these two subtypes because of prognostic differences and possible changes in management, especially in cases undergoing active surveillance. The purpose of our study is to evaluate the use of voxel-based whole-lesion (WL) enhancement parameters on contrast enhanced computed tomography (CECT) to distinguish ccRCC from pRCC. MATERIALS AND METHODS: In this institutional review board-approved study, we retrospectively queried the surgical database for post nephrectomy patients who had pathology proven ccRCC or pRCC and who had preoperative multiphase CECT of the abdomen between June 2009 and June 2011. A total of 61 patients (46 with ccRCC and 15 with pRCC) who underwent robotic assisted partial nephrectomy for clinically localized disease were included in the study. Multiphase CT acquisitions were transferred to a dedicated three-dimensional workstation, and WL regions of interest were manually segmented. Voxel-based contrast enhancement values were collected from the lesion segmentation and displayed as a histogram. Mean and median enhancement and histogram distribution parameters skewness, kurtosis, standard deviation, and interquartile range were calculated for each lesion. Comparison between ccRCC and pRCC was made using each imaging parameter. For mean and median enhancement, which had a normal distribution, independent t-test was used. For histogram distribution parameters, which were not normally distributed, Wilcoxon rank sum test was used. RESULTS: ccRCC had significantly higher mean and median whole WL enhancement (p < 0.01) compared to pRCC on arterial, nephrographic, and excretory phases. ccRCC had significantly higher interquartile range and standard deviation (p < 0.01) and significantly lower skewness (p < 0.01) compared to pRCC on arterial and nephrographic phases. ccRCC had significantly lower kurtosis compared to pRCC on only the arterial phase. CONCLUSION: Our study suggests that voxel-based WL enhancement parameters can be used as a quantitative tool to differentiate ccRCC from pRCC. Differentiating between the two main types of RCC would provide the patient and the treating physicians more information to formulate the initial approach to managing the patient’s renal cancer. Springer International Publishing 2015-02-10 /pmc/articles/PMC4325006/ /pubmed/25694862 http://dx.doi.org/10.1186/s40064-015-0823-z Text en © Chen et al.; licensee Springer. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. |
spellingShingle | Research Chen, Frank Huhdanpaa, Hannu Desai, Bhushan Hwang, Darryl Cen, Steven Sherrod, Andy Bernhard, Jean-Christophe Desai, Mihir Gill, Inderbir Duddalwar, Vinay Whole lesion quantitative CT evaluation of renal cell carcinoma: differentiation of clear cell from papillary renal cell carcinoma |
title | Whole lesion quantitative CT evaluation of renal cell carcinoma: differentiation of clear cell from papillary renal cell carcinoma |
title_full | Whole lesion quantitative CT evaluation of renal cell carcinoma: differentiation of clear cell from papillary renal cell carcinoma |
title_fullStr | Whole lesion quantitative CT evaluation of renal cell carcinoma: differentiation of clear cell from papillary renal cell carcinoma |
title_full_unstemmed | Whole lesion quantitative CT evaluation of renal cell carcinoma: differentiation of clear cell from papillary renal cell carcinoma |
title_short | Whole lesion quantitative CT evaluation of renal cell carcinoma: differentiation of clear cell from papillary renal cell carcinoma |
title_sort | whole lesion quantitative ct evaluation of renal cell carcinoma: differentiation of clear cell from papillary renal cell carcinoma |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4325006/ https://www.ncbi.nlm.nih.gov/pubmed/25694862 http://dx.doi.org/10.1186/s40064-015-0823-z |
work_keys_str_mv | AT chenfrank wholelesionquantitativectevaluationofrenalcellcarcinomadifferentiationofclearcellfrompapillaryrenalcellcarcinoma AT huhdanpaahannu wholelesionquantitativectevaluationofrenalcellcarcinomadifferentiationofclearcellfrompapillaryrenalcellcarcinoma AT desaibhushan wholelesionquantitativectevaluationofrenalcellcarcinomadifferentiationofclearcellfrompapillaryrenalcellcarcinoma AT hwangdarryl wholelesionquantitativectevaluationofrenalcellcarcinomadifferentiationofclearcellfrompapillaryrenalcellcarcinoma AT censteven wholelesionquantitativectevaluationofrenalcellcarcinomadifferentiationofclearcellfrompapillaryrenalcellcarcinoma AT sherrodandy wholelesionquantitativectevaluationofrenalcellcarcinomadifferentiationofclearcellfrompapillaryrenalcellcarcinoma AT bernhardjeanchristophe wholelesionquantitativectevaluationofrenalcellcarcinomadifferentiationofclearcellfrompapillaryrenalcellcarcinoma AT desaimihir wholelesionquantitativectevaluationofrenalcellcarcinomadifferentiationofclearcellfrompapillaryrenalcellcarcinoma AT gillinderbir wholelesionquantitativectevaluationofrenalcellcarcinomadifferentiationofclearcellfrompapillaryrenalcellcarcinoma AT duddalwarvinay wholelesionquantitativectevaluationofrenalcellcarcinomadifferentiationofclearcellfrompapillaryrenalcellcarcinoma |